HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tarenflurbil Phase II Study investigators Selected Research

Amyloid beta-Peptides

6/2008Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tarenflurbil Phase II Study investigators Research Topics

Disease

1Alzheimer Disease (Alzheimer's Disease)
06/2008
1Cognitive Dysfunction
06/2008

Drug/Important Bio-Agent (IBA)

1tarenflurbilIBA
06/2008
1Amyloid beta-PeptidesIBA
06/2008

Therapy/Procedure

1Activities of Daily Living (ADL)
06/2008